SWARNAKAMAL MISHRA

• Leading the development and delivery of a highly business-critical healthcare application used by doctors globally to order and manage cancer-curable drugs.
• Promoted to Technical Lead and Delivery Manager, managing a team of over 30 members, including developers, QA engineers, platform engineers, and business analysts.
• Own end-to-end delivery, including sprint planning, retrospectives, backlog grooming, and weekly stakeholder status calls.
• Successfully represented the offshore team during the onsite assignment in Dublin, Ireland, ensuring smooth knowledge transfer and project handover.
• Acted as a cross-cultural coordinator between global stakeholders and offshore teams, improving communication efficiency and delivery confidence.
• Received strong client appreciation for consistent delivery quality, ownership, and leadership over the last three years.
• Played a key role as Lead Developer, implementing project-critical features with high ownership.
• Delivered complex features almost single-handedly, under tight timelines.
• Recognized by the client for exceptional technical contributions and reliability.
• Provided support for Novartis project in global healthcare.
• Client: Microsoft. [2022-2023]

Key Projects:

• Spoton Logistics - Developed a web and Android solution to generate e-way bills.
• Royal Enfield – Designed and implemented Azure Logic Apps workflows to manage customer relationships and service request tracking.
• Audit 360 (PwC US) – Served as Module Lead for 2.5 years on an internal auditing platform used by major banks, including JPM, Morgan Stanley, State Street Bank, Fidelity, and many others.
  - Built and managed data processing modules, integrating multiple data sources.
  - Ensured regulatory compliance and data accuracy for large financial institutions.

• I worked for British Telecom, delivering multiple enterprise applications.
• I took ownership of production releases, issue resolution, and post-deployment support.
• Known for reliability and attention to quality during high-risk releases.